| Bioactivity | TPP-1 is a potent inhibitor of the PD-1/PD-L1 interaction. TPP-1 binds specifically to PD-L1 with a high affinity (KD=95 nM). TPP-1 inhibits human tumor growth in vivo via reactivating T-cell function[1]. | ||||||
| Invitro | TPP-1 binds to PD-L1 with high affinity and blocks PD-1/PD-L1 interaction. The KD value of PD-L1 with TPP-1 peptide is about 95 nmol/L (around five times less than that with PD-1), The binding site of TPP-1 to PD-L1 is close to the interactive site of PD-1 and PD-L1[1].TPP-1 (4 μM) reactivates T-cell functions, it induces IFNγ release significantly higher than control and SPP-1, and the TPP-1 group shows similar outcomes for cell proliferation[1]. | ||||||
| Name | TPP-1 | ||||||
| CAS | 2426685-25-6 | ||||||
| Shortening | SGQYASYHCWCWRDPGRSGGSK | ||||||
| Formula | C107H150N34O32S2 | ||||||
| Molar Mass | 2488.67 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
TPP-1
CAS: 2426685-25-6 F: C107H150N34O32S2 W: 2488.67
TPP-1 is a potent inhibitor of the PD-1/PD-L1 interaction. TPP-1 binds specifically to PD-L1 with a high affinity (KD=9
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.